Product Details
BISTLA-NEO
Pre-Probiotics 15 Billion CFU Without Cold Chain
Stable room-temperature pre-probiotics for gut health in kidney patients
Indication
Used to restore gut microbiota balance in CKD patients. Helps reduce uremic toxin production and improves intestinal barrier function. Indicated for dysbiosis management in renal patients.
Mode of Action
Contains stable probiotic strains that colonize the gut, reducing uremic toxin-producing bacteria and improving intestinal permeability. Helps reduce indoxyl sulfate and p-cresyl sulfate levels in CKD.
Dosage & Administration
As recommended or prescribed by a healthcare professional, nephrologist, transplant physician, or relevant specialist.
This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.
.png)
